Metformin with osteogenic and anti inflammatory properties Shows Promise in Periodontal Therapy: Study
Metformin demonstrates osteogenic and anti-inflammatory properties, suggesting potential as an adjunct in periodontal therapy. However, heterogeneous studies, short follow-up, and lack of meta-analysis limit conclusions, highlighting the need for robust long-term research.
A study was done to improve clinical and radiographic results in patients with periodontitis, this systematic review assessed the efficacy of metformin (MF) as an adjuvant to surgical and nonsurgical periodontal therapy. Patients with periodontitis (P), Metformin as an adjuvant (I), periodontal therapy alone, or placebo (C), and outcomes such as bone regeneration (O), clinical attachment level (CAL), and probing depth (PD), were evaluated with the PICO framework. Between June 15 and July 1, 2025, we searched for in vitro, in vivo, and randomized controlled trials (RCTs) published between June 2015 and June 2025 in PubMed, Google Scholar, ScienceDirect, and Semantic Scholar. Data were narratively synthesized according to MF concentration (0.5–1.5%), outcome measures, and patient type. The Cochrane tools SYRCLE and QUIN were used to assess risk of bias for RCTs, animal studies, and in vitro studies.
The analysis included 15 RCTs, 10 in vitro studies, and 8 in vivo studies among 4005 identified records. The most commonly used formulation was local Metformin gel. Follow-up times ranged from 1 to 9 months. Metformin, in contrast to scaling and root planing or placebo, produced vertical bone fill as high as 26.8%, a CAL gain of 1.5–2.7 mm, and a PD decrease of 1.5–3.4 mm. Experimental investigations had moderate risk of bias, whereas RCTs had low risk of bias.
Metformin's osteogenic and anti-inflammatory qualities make it a promising adjuvant in periodontal therapy. However, the need for additional long-term research was highlighted by the study heterogeneity, limited follow-up periods, and a lack of meta-analysis.
Reference:
Muhammad K.H. Uddin, Aanya Naseem, Syeda M. Aziz, Saba Rafiq, Mehak A. Sattar, Muhammad S. Zafar, Bilquees Saba, Humaira Hassan, Efficacy of metformin as an adjunct in periodontitis: A systematic analysis, Journal of Taibah University Medical Sciences,
Volume 21, Issue 2, 2026, Pages 332-348, ISSN 1658-3612, https://doi.org/10.1016/j.jtumed.2026.03.007.
(https://www.sciencedirect.com/science/article/pii/S1658361226000338)
Keywords:
Adjunctive therapy, Bone regeneration, Metformin, Periodontitis, RCTs, Muhammad K.H. Uddin, Aanya Naseem, Syeda M. Aziz, Saba Rafiq, Mehak A. Sattar, Muhammad S
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.